MET exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features

被引：0
|
作者：
Yuan, Lisi [1 ]
Bosler, David [2 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin, Beachwood, OH USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1974
引用
收藏
页码：1831 / 1832
页数：2
相关论文
共 50 条
  • [21] Coexistence of MET exon 14 mutations with EGFR mutations in non-small cell lung cancer
    Li, Wen-Feng
    Kang, Jin
    Zhang, Xu-Chao
    Jian, Su
    Chen, Huajun
    Wang, Zhen
    Wang, Bin-Chao
    Zhou, Qing
    Tu, Hai-Yan
    Wu, Yi-Long
    Yang, Jin-Ji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Identification of a Novel MET Exon 14 Skipping Variant in Non-Small Cell Lung Cancer
    Cheng, Y.
    Das, R.
    Jakubowski, M.
    Spildener, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S89 - S89
  • [23] Comprehensive characterization of MET exon 14 skipping mutations in non-small cell lung cancer
    Wu, Xue
    Zhang, Yaru
    Pang, Jiaohui
    Lin, Li
    Yin, Jiani C.
    Tang, Haimeng
    Shao, Yang
    CANCER RESEARCH, 2023, 83 (07)
  • [24] MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis
    Tong, Joanna H.
    Yeung, Sai F.
    Chan, Anthony W. H.
    Chung, Lau Y.
    Chau, Shuk L.
    Lung, Raymond Wai Ming
    Tong, Carol Y.
    Chow, Chit
    Tin, Edith K. Y.
    Yu, Yau H.
    Li, Hui
    Pan, Yi
    Chak, Wing P.
    Ng, Calvin S. H.
    Mok, Tony S. K.
    To, Ka F.
    CLINICAL CANCER RESEARCH, 2016, 22 (12) : 3048 - 3056
  • [25] CLINICOPATHOLOGIC FEATURES OF MET GENE COPY NUMBER GAIN IN NON-SMALL CELL LUNG CANCER
    Jin, Yan
    Seo, An Na
    Sun, Pingli
    Kim, Hyojin
    Chang, Hyun
    Chung, Jin-haeng
    Lee, Jong-suk
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S481 - S481
  • [26] Updated molecular analysis of MET exon 14 skipping mutations (METex14) in non-small cell lung cancer (NSCLC)
    Marks, Jennifer Aline
    Gandhi, Nishant
    Halmos, Balazs
    Ramalingam, Suresh S.
    Bazhenova, Lyudmila
    Marmarelis, Melina Elpi
    Xiu, Joanne
    Walker, Phillip
    Oberley, Matthew James
    Ma, Patrick C.
    Liu, Stephen V.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations
    Jorgensen, Jan Trost
    Urbanska, Edyta M.
    Mollerup, Jens
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 940 - 946
  • [28] Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation
    Brazel, Danielle
    Zhang, Shannon
    Nagasaka, Misako
    LUNG CANCER-TARGETS AND THERAPY, 2022, 13 : 33 - 45
  • [29] Advances in clinical research of MET exon 14 skipping mutations in non-small cell lung cancer
    Wang, Mengchao
    Zhang, Shao
    Yi, Dan
    Ou, Yan
    Xie, Shuqi
    Zeng, Chuanxiu
    Qin, Xueqian
    Zhao, Lu
    Wang, Zhen
    Kong, Fanming
    Chen, Liwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
  • [30] MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
    Ramesh, Shrey
    Cifci, Ahmet
    Javeri, Saahil
    Minne, Rachel L.
    Longhurst, Colin A.
    Nickel, Kwangok P.
    Kimple, Randall J.
    Baschnagel, Andrew M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1379 - 1390
12345